[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Integra LifeSciences Holdings (IART)

Integra LifeSciences (IART) price declines amidst analyst downgrades and supply chain concerns, despite beating Q3 earnings. Recent social posts highlight mixed sentiment with some anticipating target price increases.

About Integra LifeSciences Holdings

Integra LifeSciences Holdings is a company focused on developing, manufacturing, and marketing medical devices.
Integra LifeSciences Holdings uses the ticker $IART for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Integra LifeSciences Holdings (IART) trading volume is up XXXXXX% from the previous week.
Integra LifeSciences Holdings (IART) engagements is up XXXXX% from the previous week.
Integra LifeSciences Holdings (IART) posts created is up XXXXX% from the previous week.

Price: $XXXXX

Price 24-Hour Time-Series Raw Data
The recent decline in IART's price is likely influenced by a combination of analyst sentiment, including some downgrades and target price reductions, alongside the company's acknowledgment of supply chain challenges, despite beating Q3 earnings expectations.

24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2025-02-05
1-Year Low: $XXXXX on 2025-11-20

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Integra LifeSciences Holdings (IART) is currently AltRank #1,721 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX -XX
X Month: XXXXX -X
X Months: XXXXX -XXX
X Year: XXXXX +890
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-02-16

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX +1
X Year: XX -XX
1-Year High: XX on 2025-06-27
1-Year Low: X on 2025-09-23

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +58%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-02-25
1-Year Low: X on 2025-09-27

Engagements by network (24h): X: XXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +13%
X Months: XXXXX +45%
X Year: XXXXX +102%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-21

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Integra LifeSciences Holdings (IART) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XXXX%
X Month: XX +24%
X Months: XXX +209%
X Year: XXXXX +155%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-21

The most influential creators that mention Integra LifeSciences Holdings in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@mariostario2019	X	XX	X	XX
@BuyTheUgly	X	XX	X	XX
@stocktreats	X	XXXXX	X	XX
@Trade_market1	X	XXX	X	X

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% no change
X Months: XX% no change
X Year: XX% -XX%
1-Year High: XXX% on 2025-03-27
1-Year Low: X% on 2025-01-14

Most Supportive Themes:

Positive Q3 Earnings and Raised Guidance: (30%) Integra LifeSciences reported better-than-expected Q3 earnings, with expanding margins and strong sales in neurosurgery, leading to an increased full-year EPS forecast.
Analyst Target Price Increases: (25%) Several analysts have raised their target prices for IART, indicating positive sentiment and potential upside from investment banks.
Product and Technology Showcases: (20%) Integra LifeSciences is actively showcasing its medical devices and technologies through detailed animation and instructional videos, highlighting innovation.
FDA Clearance for Cardiac System: (15%) Integra LifeSciences received FDA clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries, a significant regulatory approval.

Most Critical Themes:

Supply Chain Challenges: (15%) Despite positive results, the company mentioned ongoing supply challenges impacting revenue growth, which could pose a risk to future performance.
Analyst Downgrades and Sell Ratings: (10%) Some analysts have downgraded IART or maintained sell ratings, citing concerns that could weigh on the stock's performance.
Ransomware Attack Mention: (5%) Integra LifeSciences was mentioned as a victim of the CL0P ransomware group, raising concerns about data security and operational disruption.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% no change
X Month: XXXXXX% +0.0018%
X Months: XXXXXX% +0.0044%
X Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXXX% on 2025-09-21

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-10
1-Year Low: XXXXXXX% on 2025-12-11

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$2.70%
X Month: $XXXXXXXXXXXXX +$12%
X Months: $XXXXXXXXXXXXX +$14%
X Year: $XXXXXXXXXXXXX -$42%
1-Year High: $XXXXXXXXXXXXX on 2025-02-05
1-Year Low: $XXXXXXXXXXX on 2025-11-20